Skip to main content
Premium Trial:

Request an Annual Quote

Lion Executives and Board Members Step Down; Ingelise Saunders Takes Helm at ACE BioSciences; Andrew Fire, Alan Guttmacher, Robert Nussbaum, and Eric Topol Elected to Institute of Medicine of the National Academies; and Others

Daniel Keesman, co-CEO and chief operating officer, and Martin Hollenhorst, co-CEO and CFO, as well as all three members of the supervisory board of Lion Bioscience - J rgen Dormann, Klaus Pohle, and Richard Roy - have resigned, the company said last week. Thure Etzold, managing director for Lion Bioscience UK, and Joseph Donahue, chief business officer for Lion Bioscience in North America, have been appointed as co-CEOs. Etzold will be responsible for product development and services, and Donahue will assume responsibility for finance and administration.


Ingelise Saunders has become CEO of proteomics company ACE BioSciences, the Odense, Denmark-based company announced earlier this month. Saunders replaces Ejvind Mørtz, who co-founded ACE in 2001. She joins ACE from Celltech Pharmaceuticals, where she was CEO for three years until the company was acquired by UCB in May.


Seattle Genetics announced three new appointments and promotions yesterday: Iqbal Grewal has become vice president for preclinical therapeutics, joining the company from Genentech, where he was a senior scientist in the department of immunology. He holds a PhD in immunology from the University of California Los Angeles, an MS in immunobiology from the Universityof Aberdeen in the UK, and a BS in biology and chemistry from PanjabUniversity in India.


Morris Rosenberg has been promoted to senior vice president of development, from vice president of development. He holds a DSc and an MS in chemical engineering and a BA in biology from WashingtonUniversity in St. Louis.


Paul Carter has been promoted to vice president for antibody technologies, from senior director for antibody technologies. He received a PhD in molecular biology and a BA in natural sciences from CambridgeUniversity.


Aaron Shatkin has been elected to the board of directors of Serologicals, the company said last week. Shatkin is currently the director of the Center for Advanced Biotechnology and Medicine, as well as a professor of molecular genetics and microbiology at the Robert W. Johnson Medical School in Piscataway, NJ. He is also a professor of molecular biology at RutgersUniversity.


Kevin Farr has been elected to the board of directors of Beckman Coulter, effective Oct. 8, the company said last week. He is the chief financial officer for Mattel. Farr holds an MBA from Northwestern University's J L Kellogg Graduate School of Business and a bachelor's degree from Michigan State University.


Richard Ulevitch has been named to the scientific advisory board of MultiCell, the company said last week. He is currently chairman of the department of immunology at The Scripps Research Institute in La Jolla, Calif. Ulevitch received a PhD in biochemistry from the Universityof Pennsylvania.


Nick Samaras has been appointed to the board of directors of the Australian Genome Research Facility, he announced last week. Samaras is the founding executive director of Australis Biosciences, a consulting company based in Melbourne. Prior to that, he was the managing director for Australia and New Zealand at Applied Biosystems. Samaras holds a PhD in molecular parasitology from the University of Melbourne, a BSc in pathology and immunology from Monash University, and an MBA from RMIT University.


Steven Knapp has joined the Center for Applied Genetic Technologies at the Universityof Georgia as a Georgia Research Alliance Eminent Scholar in crop genomics, the Georgia Research Alliance said earlier this month. Knapp joins Georgia after 20 years at Oregon State University where he was chairman of the crop and soil science department. He holds a PhD in agronomy and plant breeding from the Universityof Nebraska.


Andrew Fire, Alan Guttmacher, Robert Nussbaum, and Eric Topol are among the 65 new members of the Instituteof Medicine of the National Academies that were announced on Monday. New members are recognized for major contributions to the advancement of the medical sciences, health care, and public health, according to the IOM.


Fire is a professor of pathology and genetics at Stanford University School of Medicine; Guttmacher is the deputy director of the National Human Genome Research Institute; Nussbaum is chief of the genetic disease research branch at NHGRI; and Topol is chairman of the department of cardiovascular medicine at the Cleveland Clinic and professor of medicine and genetics at Case Western Reserve University.


Kelly Ormond was elected as president of the National Society of Genetic Counselors at the society's annual conference in WashingtonDC, NSGC said earlier this month. She is an assistant professor in the department of medicine and the director of the graduate program in genetic counseling at NorthwesternUniversity. Ormond holds a master's degree in genetic counseling from NorthwesternUniversity.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.